AAAAAA

   
Results: 1-3 |
Results: 3
Msh-2 suppresses in vivo mutation in a gene dose and lesion dependent manner
Authors: Sansom, OJ Toft, NJ Winton, DJ Clarke, AR
Citation: Oj. Sansom et al., Msh-2 suppresses in vivo mutation in a gene dose and lesion dependent manner, ONCOGENE, 20(27), 2001, pp. 3580-3584
In vivo administration of O-6-benzylguanine does not influence apoptosis or mutation frequency following DNA damage in the murine intestine, but doesinhibit P450-dependent activation of dacarbazine
Authors: Toft, NJ Sanson, OJ Brookes, RA Arends, MJ Wood, M Margison, GP Winton, DJ Clarke, AR
Citation: Nj. Toft et al., In vivo administration of O-6-benzylguanine does not influence apoptosis or mutation frequency following DNA damage in the murine intestine, but doesinhibit P450-dependent activation of dacarbazine, CARCINOGENE, 21(4), 2000, pp. 593-598
Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine
Authors: Toft, NJ Winton, DJ Kelly, J Howard, LA Dekker, M Riele, HT Arends, MJ Wyllie, AH Margison, GP Clarke, AR
Citation: Nj. Toft et al., Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine, P NAS US, 96(7), 1999, pp. 3911-3915
Risultati: 1-3 |